Review ArticleOpen accessEvery word in the title"Ebola Ça Suffit!" is not enough to Prove Efficacy of an Ebola VaccineDavid R CroweA recently published Ebola vaccine trial claimed an almost perfect result with no cases of Ebola after the vaccine had time to take effect - a vaccine efficacy of 100%. This article is a detailed review of the information published about the trial and, particularly, this claim. The trial design was sub-optimal because randomization was only partial (and one treatment … …American Journal of Immunology, Vol. 13, Issue 3 · 8 Jul 2017 · 17,825 accessesView PDFCite
EditorialOpen accessEvery word in the titleCURRENT SCENARIO OF THERAPEUTICS FOR EBOLA VIRUS DISEASEML Arvinda Swamy, Madhavan P.N. Nair, Shailendra K. SaxenaCurrently various countries in Africa, including Liberia, Sierra Leone, Guinea, Nigeria, are facing disaster due to Ebola Virus Disease (EVD), which is primarily caused by Ebola virus. 2014 outbreak of Ebola associated viral haemorrhagic fever has 55-60% fatality rate. The incubation period of Ebola is below 21 days; once the appearance of symptoms starts the person will be infective. As … …American Journal of Infectious Diseases, Vol. 10, Issue 3 · 3 Sep 2014 · 7,744 accessesView PDFCite
Research ArticleOpen accessEvery word in the titleHEALTH BROKEN WOVEN POISSON SPHERES TO MANAGE DEADLY EBOLA INCIDENCESRamalingam ShanmugamThe deadly infectious Ebola incidences scare not only to the residents of western Africa but also to the travelers and medical professionals who treat the patients, as they became victims. Since 27 July until 13 August 2014 alone, about 2,127 Ebola cases occurred in just four Western African countries: Guinea, Liberia, Nigeria and Sierra Leone and more than 50% of … …American Journal of Infectious Diseases, Vol. 10, Issue 3 · 15 Oct 2014 · 6,685 accessesView PDFCite
Review ArticleOpen accessIn the abstractCurrent Laboratory Biosecurity for Handling Pathogenic VirusesI Made Artika, Chairin Nisa Ma’roefThe recent emergence of lethal viruses such as Ebola raises some concern about the possibility of the viruses being used as biological weapons. The application of pathogenic viruses as biothreat agents in the past is well documented. Although their use in warfare is currently prohibited by the Biological and Toxin Weapon Convention, their potential use in bioterrorism is a global … …American Journal of Biochemistry and Biotechnology, Vol. 14, Issue 2 · 6 Apr 2018 · 10,625 accessesView PDFCite
Review ArticleOpen accessIn the abstractRecent Advances in Point of Care Diagnostic Tools: A ReviewLaura Wessels, Haider RaadGlobally, there is a great need for portable, inexpensive diagnostic tools that can provide quick, accurate results using relatively small sample volumes. Point-Of-Care (POC) measurements of human saliva, sweat and/or blood capable of detecting glucose levels, foreign pathogens such as bacteria, fungi and many different viruses (HIV, Ebola, Influenza, etc.) that use microfluidics and optofluidics are close to commercial availability. … …American Journal of Engineering and Applied Sciences, Vol. 9, Issue 4 · 28 Nov 2016 · 8,234 accessesView PDFCite